
Enamine joins forces with the ICR to expand fragment-based drug discovery with fluorinated compound libraries
KYIV, UKRAINE, September 23, 2025 /EINPresswire.com/ -- Enamine Ltd., a leading global provider of screening compounds, chemical building blocks, and drug discovery services, and The Institute of Cancer Research, London, have announced a new research …